How the cloud enables innovation for pharma and life sciences

Cloud-based technologies have the potential to greatly benefit the pharmaceutical industry by providing scalability and access to greater resources. Artificial intelligence strategies, such as drug discovery, could be enabled by the cloud. However, experts warn that the cloud may not automatically reduce costs or provide benefits, and security concerns remain a major obstacle. There is an opportunity for the industry to use the cloud for data sharing, research collaboration, and improving supply chain processes. IT departments in pharmaceutical companies may be constrained by cost-cutting measures and rely on third parties for cloud-based innovation.